Prior studies have linked increased CXCR4 promoter cytosine methylation (5mC) to decreased CXCR4 protein expression in several non-colonic cancers such as primary breast cancer [29], decreased mRNA and protein in melanoma cell lines [47] and primary cervical cancer [48]. This evidence concerns the gene CXCR4 and cervical carcinoma.